{"id":"https://openalex.org/W181027484","doi":null,"title":"Combined treatment with venlafaxine and tricyclic antidepressants in depressed patients who had partial response to clomipramine or imipramine: initial findings.","display_name":"Combined treatment with venlafaxine and tricyclic antidepressants in depressed patients who had partial response to clomipramine or imipramine: initial findings.","alternate_titles":[],"publication_year":2000,"publication_date":"2000-04-01","ids":{"openalex":"https://openalex.org/W181027484","mag":"181027484","pmid":"https://pubmed.ncbi.nlm.nih.gov/10830150"},"language":"en","primary_location":{"id":"pmid:10830150","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10830150","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Clinical Trial"},"parent_works":[],"lineage":["https://openalex.org/W181027484"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077007598","display_name":"G\u00f3mez G\u00f3mez Jm","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J M G\u00f3mez G\u00f3mez","raw_affiliation_strings":["Mental Health Center-Fundaci\u00f3 Sanit\u00e0ria d'Igualada, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mental Health Center-Fundaci\u00f3 Sanit\u00e0ria d'Igualada, Barcelona, Spain","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022136773","display_name":"C Teixid\u00f3 Perram\u00f3n","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Teixid\u00f3 Perram\u00f3n","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3406,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.62479848,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"61","issue":"4","first_page":"285","last_page":"289"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venlafaxine","display_name":"venlafaxine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tricyclic-antidepressants","display_name":"tricyclic antidepressants","score":0.9649999737739563},{"id":"https://openalex.org/keywords/clomipramine","display_name":"clomipramine","score":0.9430000185966492},{"id":"https://openalex.org/keywords/imipramine","display_name":"imipramine","score":1.0},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.640999972820282},{"id":"https://openalex.org/keywords/recurrent-depressive-disorder","display_name":"recurrent depression","score":0.6639999747276306},{"id":"https://openalex.org/keywords/antidepressant-augmentation","display_name":"antidepressant augmentation","score":0.847000002861023},{"id":"https://openalex.org/keywords/partial-response","display_name":"partial response","score":0.7599999904632568},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.5450000166893005}],"concepts":[{"id":"https://openalex.org/C2776466888","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine","level":4,"score":0.8314142227172852},{"id":"https://openalex.org/C2779305415","wikidata":"https://www.wikidata.org/wiki/Q58713","display_name":"Clomipramine","level":2,"score":0.8297695517539978},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8215965628623962},{"id":"https://openalex.org/C2779145073","wikidata":"https://www.wikidata.org/wiki/Q58396","display_name":"Imipramine","level":3,"score":0.6641313433647156},{"id":"https://openalex.org/C2781081902","wikidata":"https://www.wikidata.org/wiki/Q3539074","display_name":"Tricyclic","level":2,"score":0.5899119973182678},{"id":"https://openalex.org/C2777953023","wikidata":"https://www.wikidata.org/wiki/Q1073121","display_name":"Heart rate","level":3,"score":0.5419564843177795},{"id":"https://openalex.org/C2776466505","wikidata":"https://www.wikidata.org/wiki/Q385555","display_name":"Hamilton Rating Scale for Depression","level":4,"score":0.5115422010421753},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.5038534998893738},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.49060145020484924},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4877346456050873},{"id":"https://openalex.org/C2777529043","wikidata":"https://www.wikidata.org/wiki/Q741713","display_name":"Panic disorder","level":3,"score":0.4829968214035034},{"id":"https://openalex.org/C2909532165","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine Hydrochloride","level":5,"score":0.44990476965904236},{"id":"https://openalex.org/C83849319","wikidata":"https://www.wikidata.org/wiki/Q7295720","display_name":"Rating scale","level":2,"score":0.4461357891559601},{"id":"https://openalex.org/C2780712732","wikidata":"https://www.wikidata.org/wiki/Q208450","display_name":"Panic","level":3,"score":0.4409107267856598},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43206387758255005},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3969588577747345},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.3588060140609741},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2717137932777405},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.24484971165657043},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.2410801649093628},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.144607812166214},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.13188382983207703},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C138496976","wikidata":"https://www.wikidata.org/wiki/Q175002","display_name":"Developmental psychology","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C2779144063","wikidata":"https://www.wikidata.org/wiki/Q338924","display_name":"Amygdala","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069470","descriptor_name":"Venlafaxine Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000929","descriptor_name":"Antidepressive Agents, Tricyclic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002997","descriptor_name":"Clomipramine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003511","descriptor_name":"Cyclohexanols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007099","descriptor_name":"Imipramine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:10830150","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10830150","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Clinical Trial"},{"id":"mag:181027484","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10830150","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2064158398","https://openalex.org/W2127568033","https://openalex.org/W2365473936","https://openalex.org/W2356634874","https://openalex.org/W1998820173","https://openalex.org/W2356383011","https://openalex.org/W2903554232","https://openalex.org/W2368245390","https://openalex.org/W2368370189","https://openalex.org/W2143247032"],"abstract_inverted_index":{"BACKGROUND:":[0],"We":[1,163],"report,":[2],"after":[3,55,160,185],"3":[4],"years":[5],"of":[6,22,44,46,57,67,77,124,153,158,258,284],"work,":[7],"a":[8,70,119],"case":[9],"series":[10],"showing":[11],"our":[12],"initial":[13,286],"results":[14],"(efficacy,":[15],"tolerability,":[16],"and":[17,51,75,103,113,156,176,181,209,236,246,268],"safety)":[18],"with":[19,275],"the":[20,139,149,168,226],"addition":[21,56],"venlafaxine":[23,116,187,259],"immediate":[24],"release":[25],"(IR)":[26],"to":[27,41,118,260,278],"either":[28],"clomipramine":[29,261],"or":[30,90,250,262],"imipramine":[31,263],"in":[32,85,196,201,206,220,225,243,272],"depressed":[33],"patients":[34,63,87,228,274],"who":[35],"had":[36],"shown":[37],"only":[38],"partial":[39,276],"response":[40,277],"maximal":[42],"doses":[43],"one":[45],"those":[47],"tricyclic":[48,252],"antidepressants":[49],"(TCAs)":[50],"no":[52,132,234],"further":[53],"improvement":[54,192],"usual":[58,99],"augmentation":[59,270],"drugs.":[60],"METHOD:":[61],"Eleven":[62],"were":[64,233,254],"treated,":[65],"10":[66],"them":[68,78],"having":[69,79],"recurrent":[71],"depressive":[72,273],"disorder":[73],"(DSM-IV)":[74,83],"all":[76],"current":[80],"major":[81],"depression":[82],"that":[84],"9":[86,207],"was":[88,131,136,238],"moderate":[89],"severe":[91],"despite":[92],"intense":[93],"TCA":[94,108,183],"treatment":[95],"as":[96,98],"well":[97],"augmentations.":[100],"Under":[101],"open":[102],"outpatient":[104],"conditions,":[105],"we":[106],"maintained":[107],"doses,":[109],"discontinued":[110],"previous":[111],"augmentations,":[112],"then":[114],"added":[115],"IR":[117],"maximum":[120],"dosage,":[121],"if":[122],"necessary,":[123],"150":[125],"mg":[126],"every":[127],"12":[128],"hours.":[129],"There":[130,232],"control":[133],"group.":[134],"Response":[135],"assessed":[137],"using":[138],"17-item":[140],"Hamilton":[141],"Rating":[142,172],"Scale":[143],"for":[144],"Depression":[145],"(HAM-D),":[146],"DSM-IV":[147,202],"criteria,":[148],"Clinical":[150],"Global":[151],"Impressions-Severity":[152],"Illness":[154],"scale,":[155],"persistence":[157],"improvements":[159],"6":[161],"months.":[162],"measured":[164],"clinical":[165],"tolerance":[166],"(using":[167],"UKU":[169],"Side":[170],"Effect":[171],"Scale),":[173],"blood":[174,182,244,251],"pressure":[175,245],"heart":[177,247],"rate,":[178,248],"electrocardiogram":[179],"(ECG),":[180],"levels":[184,253],"adding":[186],"IR.":[188],"RESULTS:":[189],"A":[190,281],"sustained":[191,210],"(>":[193],"50%":[194],"decrease":[195,200],"HAM-D":[197,216],"score":[198,217],"plus":[199,215],"severity":[203],"level)":[204],"appeared":[205],"patients,":[208],"full":[211],"remission":[212],"(DSM-IV":[213],"criteria":[214],"<":[218],"5)":[219],"7.":[221],"Panic-agoraphobic":[222],"symptoms":[223],"improved":[224],"2":[227],"suffering":[229],"from":[230],"them.":[231],"dropouts,":[235],"tolerability":[237],"good.":[239],"No":[240],"significant":[241],"changes":[242],"ECG,":[249],"found.":[255],"CONCLUSION:":[256],"Addition":[257],"could":[264],"be":[265],"an":[266],"effective":[267],"safe":[269],"strategy":[271],"maximum-dose":[279],"monotherapy.":[280],"consistent":[282],"replication":[283],"these":[285],"findings":[287],"is":[288],"strongly":[289],"needed.":[290]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W181027484","counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
